table of content
1 Introduction to Research & Analysis Reports
1.1 Cell and Gene Therapy Manufacturing QC Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cell and Gene Therapy Manufacturing QC Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cell and Gene Therapy Manufacturing QC Overall Market Size
2.1 Global Cell and Gene Therapy Manufacturing QC Market Size: 2022 VS 2030
2.2 Global Cell and Gene Therapy Manufacturing QC Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cell and Gene Therapy Manufacturing QC Players in Global Market
3.2 Top Global Cell and Gene Therapy Manufacturing QC Companies Ranked by Revenue
3.3 Global Cell and Gene Therapy Manufacturing QC Revenue by Companies
3.4 Top 3 and Top 5 Cell and Gene Therapy Manufacturing QC Companies in Global Market, by Revenue in 2022
3.5 Global Companies Cell and Gene Therapy Manufacturing QC Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cell and Gene Therapy Manufacturing QC Players in Global Market
3.6.1 List of Global Tier 1 Cell and Gene Therapy Manufacturing QC Companies
3.6.2 List of Global Tier 2 and Tier 3 Cell and Gene Therapy Manufacturing QC Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Cell and Gene Therapy Manufacturing QC Market Size Markets, 2022 & 2030
4.1.2 Safety Testing
4.1.3 Purity Testing
4.1.4 Potency Testing
4.1.5 Identity Testing
4.1.6 Stability Testing
4.2 By Type - Global Cell and Gene Therapy Manufacturing QC Revenue & Forecasts
4.2.1 By Type - Global Cell and Gene Therapy Manufacturing QC Revenue, 2018-2023
4.2.2 By Type - Global Cell and Gene Therapy Manufacturing QC Revenue, 2024-2030
4.2.3 By Type - Global Cell and Gene Therapy Manufacturing QC Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cell and Gene Therapy Manufacturing QC Market Size, 2022 & 2030
5.1.2 Precision Therapy
5.1.3 Biological Research
5.2 By Application - Global Cell and Gene Therapy Manufacturing QC Revenue & Forecasts
5.2.1 By Application - Global Cell and Gene Therapy Manufacturing QC Revenue, 2018-2023
5.2.2 By Application - Global Cell and Gene Therapy Manufacturing QC Revenue, 2024-2030
5.2.3 By Application - Global Cell and Gene Therapy Manufacturing QC Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Cell and Gene Therapy Manufacturing QC Market Size, 2022 & 2030
6.2 By Region - Global Cell and Gene Therapy Manufacturing QC Revenue & Forecasts
6.2.1 By Region - Global Cell and Gene Therapy Manufacturing QC Revenue, 2018-2023
6.2.2 By Region - Global Cell and Gene Therapy Manufacturing QC Revenue, 2024-2030
6.2.3 By Region - Global Cell and Gene Therapy Manufacturing QC Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Cell and Gene Therapy Manufacturing QC Revenue, 2018-2030
6.3.2 US Cell and Gene Therapy Manufacturing QC Market Size, 2018-2030
6.3.3 Canada Cell and Gene Therapy Manufacturing QC Market Size, 2018-2030
6.3.4 Mexico Cell and Gene Therapy Manufacturing QC Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Cell and Gene Therapy Manufacturing QC Revenue, 2018-2030
6.4.2 Germany Cell and Gene Therapy Manufacturing QC Market Size, 2018-2030
6.4.3 France Cell and Gene Therapy Manufacturing QC Market Size, 2018-2030
6.4.4 U.K. Cell and Gene Therapy Manufacturing QC Market Size, 2018-2030
6.4.5 Italy Cell and Gene Therapy Manufacturing QC Market Size, 2018-2030
6.4.6 Russia Cell and Gene Therapy Manufacturing QC Market Size, 2018-2030
6.4.7 Nordic Countries Cell and Gene Therapy Manufacturing QC Market Size, 2018-2030
6.4.8 Benelux Cell and Gene Therapy Manufacturing QC Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Cell and Gene Therapy Manufacturing QC Revenue, 2018-2030
6.5.2 China Cell and Gene Therapy Manufacturing QC Market Size, 2018-2030
6.5.3 Japan Cell and Gene Therapy Manufacturing QC Market Size, 2018-2030
6.5.4 South Korea Cell and Gene Therapy Manufacturing QC Market Size, 2018-2030
6.5.5 Southeast Asia Cell and Gene Therapy Manufacturing QC Market Size, 2018-2030
6.5.6 India Cell and Gene Therapy Manufacturing QC Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Cell and Gene Therapy Manufacturing QC Revenue, 2018-2030
6.6.2 Brazil Cell and Gene Therapy Manufacturing QC Market Size, 2018-2030
6.6.3 Argentina Cell and Gene Therapy Manufacturing QC Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cell and Gene Therapy Manufacturing QC Revenue, 2018-2030
6.7.2 Turkey Cell and Gene Therapy Manufacturing QC Market Size, 2018-2030
6.7.3 Israel Cell and Gene Therapy Manufacturing QC Market Size, 2018-2030
6.7.4 Saudi Arabia Cell and Gene Therapy Manufacturing QC Market Size, 2018-2030
6.7.5 UAE Cell and Gene Therapy Manufacturing QC Market Size, 2018-2030
7 Cell and Gene Therapy Manufacturing QC Companies Profiles
7.1 Bio-Techne Corporation
7.1.1 Bio-Techne Corporation Company Summary
7.1.2 Bio-Techne Corporation Business Overview
7.1.3 Bio-Techne Corporation Cell and Gene Therapy Manufacturing QC Major Product Offerings
7.1.4 Bio-Techne Corporation Cell and Gene Therapy Manufacturing QC Revenue in Global Market (2018-2023)
7.1.5 Bio-Techne Corporation Key News & Latest Developments
7.2 BioMerieux SA
7.2.1 BioMerieux SA Company Summary
7.2.2 BioMerieux SA Business Overview
7.2.3 BioMerieux SA Cell and Gene Therapy Manufacturing QC Major Product Offerings
7.2.4 BioMerieux SA Cell and Gene Therapy Manufacturing QC Revenue in Global Market (2018-2023)
7.2.5 BioMerieux SA Key News & Latest Developments
7.3 Catalent, Inc.
7.3.1 Catalent, Inc. Company Summary
7.3.2 Catalent, Inc. Business Overview
7.3.3 Catalent, Inc. Cell and Gene Therapy Manufacturing QC Major Product Offerings
7.3.4 Catalent, Inc. Cell and Gene Therapy Manufacturing QC Revenue in Global Market (2018-2023)
7.3.5 Catalent, Inc. Key News & Latest Developments
7.4 Charles River Laboratories International Inc.
7.4.1 Charles River Laboratories International Inc. Company Summary
7.4.2 Charles River Laboratories International Inc. Business Overview
7.4.3 Charles River Laboratories International Inc. Cell and Gene Therapy Manufacturing QC Major Product Offerings
7.4.4 Charles River Laboratories International Inc. Cell and Gene Therapy Manufacturing QC Revenue in Global Market (2018-2023)
7.4.5 Charles River Laboratories International Inc. Key News & Latest Developments
7.5 Eurofins Scientific SE
7.5.1 Eurofins Scientific SE Company Summary
7.5.2 Eurofins Scientific SE Business Overview
7.5.3 Eurofins Scientific SE Cell and Gene Therapy Manufacturing QC Major Product Offerings
7.5.4 Eurofins Scientific SE Cell and Gene Therapy Manufacturing QC Revenue in Global Market (2018-2023)
7.5.5 Eurofins Scientific SE Key News & Latest Developments
7.6 F. Hoffmann-La Roche Ltd
7.6.1 F. Hoffmann-La Roche Ltd Company Summary
7.6.2 F. Hoffmann-La Roche Ltd Business Overview
7.6.3 F. Hoffmann-La Roche Ltd Cell and Gene Therapy Manufacturing QC Major Product Offerings
7.6.4 F. Hoffmann-La Roche Ltd Cell and Gene Therapy Manufacturing QC Revenue in Global Market (2018-2023)
7.6.5 F. Hoffmann-La Roche Ltd Key News & Latest Developments
7.7 Intertek Group plc
7.7.1 Intertek Group plc Company Summary
7.7.2 Intertek Group plc Business Overview
7.7.3 Intertek Group plc Cell and Gene Therapy Manufacturing QC Major Product Offerings
7.7.4 Intertek Group plc Cell and Gene Therapy Manufacturing QC Revenue in Global Market (2018-2023)
7.7.5 Intertek Group plc Key News & Latest Developments
7.8 Lonza Group AG
7.8.1 Lonza Group AG Company Summary
7.8.2 Lonza Group AG Business Overview
7.8.3 Lonza Group AG Cell and Gene Therapy Manufacturing QC Major Product Offerings
7.8.4 Lonza Group AG Cell and Gene Therapy Manufacturing QC Revenue in Global Market (2018-2023)
7.8.5 Lonza Group AG Key News & Latest Developments
7.9 Merck KGaA
7.9.1 Merck KGaA Company Summary
7.9.2 Merck KGaA Business Overview
7.9.3 Merck KGaA Cell and Gene Therapy Manufacturing QC Major Product Offerings
7.9.4 Merck KGaA Cell and Gene Therapy Manufacturing QC Revenue in Global Market (2018-2023)
7.9.5 Merck KGaA Key News & Latest Developments
7.10 Sartorius AG
7.10.1 Sartorius AG Company Summary
7.10.2 Sartorius AG Business Overview
7.10.3 Sartorius AG Cell and Gene Therapy Manufacturing QC Major Product Offerings
7.10.4 Sartorius AG Cell and Gene Therapy Manufacturing QC Revenue in Global Market (2018-2023)
7.10.5 Sartorius AG Key News & Latest Developments
7.11 SGS S.A.
7.11.1 SGS S.A. Company Summary
7.11.2 SGS S.A. Business Overview
7.11.3 SGS S.A. Cell and Gene Therapy Manufacturing QC Major Product Offerings
7.11.4 SGS S.A. Cell and Gene Therapy Manufacturing QC Revenue in Global Market (2018-2023)
7.11.5 SGS S.A. Key News & Latest Developments
7.12 Sistemic Scotland Limited
7.12.1 Sistemic Scotland Limited Company Summary
7.12.2 Sistemic Scotland Limited Business Overview
7.12.3 Sistemic Scotland Limited Cell and Gene Therapy Manufacturing QC Major Product Offerings
7.12.4 Sistemic Scotland Limited Cell and Gene Therapy Manufacturing QC Revenue in Global Market (2018-2023)
7.12.5 Sistemic Scotland Limited Key News & Latest Developments
7.13 Thermo Fisher Scientific Inc.
7.13.1 Thermo Fisher Scientific Inc. Company Summary
7.13.2 Thermo Fisher Scientific Inc. Business Overview
7.13.3 Thermo Fisher Scientific Inc. Cell and Gene Therapy Manufacturing QC Major Product Offerings
7.13.4 Thermo Fisher Scientific Inc. Cell and Gene Therapy Manufacturing QC Revenue in Global Market (2018-2023)
7.13.5 Thermo Fisher Scientific Inc. Key News & Latest Developments
7.14 Vigene Biosciences, Inc.
7.14.1 Vigene Biosciences, Inc. Company Summary
7.14.2 Vigene Biosciences, Inc. Business Overview
7.14.3 Vigene Biosciences, Inc. Cell and Gene Therapy Manufacturing QC Major Product Offerings
7.14.4 Vigene Biosciences, Inc. Cell and Gene Therapy Manufacturing QC Revenue in Global Market (2018-2023)
7.14.5 Vigene Biosciences, Inc. Key News & Latest Developments
7.15 WuXi AppTec
7.15.1 WuXi AppTec Company Summary
7.15.2 WuXi AppTec Business Overview
7.15.3 WuXi AppTec Cell and Gene Therapy Manufacturing QC Major Product Offerings
7.15.4 WuXi AppTec Cell and Gene Therapy Manufacturing QC Revenue in Global Market (2018-2023)
7.15.5 WuXi AppTec Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
